Skip to main content

Want a detailed portfolio tracker?

Adicet Bio (ACET) P/E (2018 - 2026)

Adicet Bio (ACET) P/E from Jan 26, 2018 to Jul 21, 2026. The TTM Adicet Bio (ACET) P/E is -0.49. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Adicet Bio (ACET)

YearP/EChange
2026-0.49+16.06%
2025-0.43-37.16%
2024-0.68+18.99%
2023-0.57-91.35%
2022-6.58-59.06%
2021-16.06-26.44%
2020-21.84+62.72%
2019-13.42-92.62%
2018-181.86N/A

Comparison Adicet Bio (ACET) P/E with competitors

Adicet Bio (ACET) P/E is -0.49.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.34%
NBYStablecoin Development Corp0.00-100.87%
ENLVEnlivex Ltd0.07-115.16%
FGENFibroGen Inc0.24-148.64%
CHRSCoherus Biosciences Inc0.85-271.94%
FBIOFortress Biotech Inc0.95-292.31%
ORMPOramed Pharmaceuticals Inc1.50-404.57%
AGENAgenus Inc3.01-709.85%
INVAInnoviva Inc3.15-739.11%
VXRTVaxart Inc3.55-819.30%
CRMDCorMedix Inc3.63-835.24%
CVACCureVac N.V.4.45-1000.84%
GLPGGalapagos NV4.86-1084.57%
SRPTSarepta Therapeutics Inc4.88-1089.28%
ABEOAbeona Therapeutics Inc5.39-1191.69%
ZVRAZevra Therapeutics Inc5.89-1292.95%
SPROSpero Therapeutics Inc6.23-1362.09%
CGENCompugen Ltd6.31-1379.42%
RIGLRigel Pharmaceuticals6.87-1492.51%
SLXNSilexion Therapeutics Corp7.30-1578.43%
OMEROmeros Corporation9.26-1976.14%
AUPHAurinia Pharmaceuticals Inc9.58-2042.24%
PLXProtalix BioTherapeutics Inc10.89-2306.89%
ACADAcadia Pharmaceuticals Inc11.73-2476.60%
TBPHTheravance Biopharma Inc12.26-2584.73%
ADMAAdma Biologics Inc12.42-2616.34%
HRMYHarmony Biosciences Holdings Inc13.82-2900.45%
SABSSAB Biotherapeutics Inc14.14-2964.48%
NAGENiagen Bioscience Inc14.82-3102.66%
INCYIncyte Corp15.82-3306.20%
REGNRegeneron Pharmaceuticals Inc15.86-3313.11%
PBYIPuma Biotechnology Inc17.32-3608.76%
CPRXCatalyst Pharmaceuticals Inc17.44-3633.81%
EXELExelixis Inc17.54-3653.81%
TGTXTG Therapeutics Inc18.97-3943.18%
MDXGMimedx Group Inc20.55-4264.65%
XOMAXOMA Royalty Corp22.87-4735.33%
ARGXArgen X SE24.30-5023.75%
CTMXCytomX Therapeutics Inc24.82-5129.75%
XOMAOXOMA Royalty Corp25.34-5235.87%
HALOHalozyme Therapeutics Inc25.62-5292.39%
XOMAPXOMA Royalty Corp25.67-5301.79%
VRTXVertex Pharmaceuticals Inc27.99-5772.85%
RPRXRoyalty Pharma plc - Class A28.69-5913.24%
SLNOSoleno Therapeutics Inc29.02-5979.67%
ASNDAscendis Pharma A/S30.09-6196.53%
LGNDLigand Pharmaceuticals Inc - Class B37.91-7782.49%
APLSApellis Pharmaceuticals Inc39.02-8007.26%
BMRNBiomarin Pharmaceutical Inc42.21-8653.81%
KRYSKrystal Biotech Inc45.34-9288.40%
ONCBeiGene Ltd69.54-14191.68%
PHARPharming Group N.V.75.03-15303.19%
TECHBio-Techne Corp101.96-20760.85%
VCELVericel Corp109.92-22374.47%
ALNYAlnylam Pharmaceuticals Inc117.96-24004.46%
GMABGenmab140.29-28528.53%
TLXTelix Pharmaceuticals Ltd162.15-32958.67%
CORTCorcept Therapeutics Inc212.86-43233.47%